The North America Subcutaneous Immunoglobulins Market is driven by rising awareness of immunoglobulin replacement therapy, expanding specialty care networks, and advancements in infusion devices and treatment formulations. The United States remains a major contributor, while Canada is also witnessing growing adoption of subcutaneous administration as healthcare providers and patients seek...